FDA Panel Backs First mRNA Flu Shot for Older Americans

A breakthrough flu vaccine using the same technology that helped end the COVID-19 pandemic just cleared a major hurdle, potentially offering faster protection for millions of seniors.

The FDA's expert panel unanimously recommended approval of Moderna's mRNA flu shot for Americans over 50.